Active Ingredient History

  • Now
Aripiprazole is the first next-generation atypical antipsychotic. The unique actions of aripiprazole in humans are likely a combination of "functionally selective" activation of D(2) (and possibly D(3))-dopamine receptors and serotonin 5-HT(1A) receptors, coupled with inhibition of 5-HT(2A) receptors. Aripiprazole was approved by FDA (Abilify trade name) for the treatment of schizophrenia; manic and mixed episodes associated with bipolar I disorder; major depressive disorder; irritability associated with autistic disorder; Tourette’s disorder and agitation associated with schizophrenia or bipolar mania.   NCATS

  • Mol. Mass: 448.385
  • ALogP: 4.86
  • ChEMBL Molecules:
More Chemistry

Drug Pricing (per unit)

United States

$0.0540 - $3169.0000


$1.5930 - $3.3529
More Pricing Detail

Note: This drug pricing data is preliminary, incomplete, and may contain errors.

abilify | abilify maintena | abilitat | alks 9072 | aripiprazol | aripiprazole | aripiprazole hydrate | aripiprazole lauroxil | aripiprazolum | aripirprazole | arista | aristada | arpiprazole | arpizol | opc-14597 | opc 31 | opc-31 | pripiprazole | rdc-3317


Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue